2289 — Charmacy Pharmaceutical Co Balance Sheet
0.000.00%
- HK$628.56m
- HK$1.13bn
- CNY4.38bn
Annual balance sheet for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | CAS | CAS | CAS | CAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 630 | 493 | 634 | 563 | 754 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 786 | 994 | 1,019 | 1,283 | 1,274 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,238 | 2,462 | 2,812 | 3,030 | 3,561 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 348 | 294 | 329 | 318 | 295 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,763 | 2,866 | 3,248 | 3,457 | 3,960 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,159 | 2,256 | 2,619 | 2,789 | 3,281 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,259 | 2,271 | 2,650 | 2,838 | 3,344 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 504 | 595 | 598 | 619 | 616 |
| Total Liabilities & Shareholders' Equity | 2,763 | 2,866 | 3,248 | 3,457 | 3,960 |
| Total Common Shares Outstanding |